An Insight into Ultrastructural and Morphological Alterations of Platelets in Neurodegenerative Diseases

REFERENCES

• Beal MF. Mitochondria and the pathogenesis of ALS. Brain. 2000 Jul; 123 (7):1291–1292.
   PubMedGoogle Scholar
• Born GVR. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature. 1962;194–927.
   Google Scholar
• Bornman MS, Pretorius E, Marx J, Smit E,van der Merwe CF. Ultrastructural effects of DDT, DDD and DDE on neural cells of the chicken embryo model. Environ Toxicol. 2007; 22: 328–336.
   PubMed Web of Science ®Google Scholar
• Borroni B, Agosti C, Marcello E, Di Luca M, Padovani A. Blood cell markers in Alzheimer disease: amyloid precursor protein form ratio in platelets. Exp Gerontol. 2010 Jan;45(1):53–56.
   PubMed Web of Science ®Google Scholar
• Bos IW, Hoogland G, Meine Jansen CF, et al. Increasedglutamine synthetase but normal EAAT2 expression in platelets of ALS patients. Neurochem Int. 2006 Mar; 48(4):306–311.
   PubMed Web of Science ®Google Scholar
• Capisizu A, Onicescu D, Ionescu N. Ultrastructural features of blood cells in atherosclerosis. Rom J Morphol Embryol. 2007;48(1):47–50.
   PubMedGoogle Scholar
• Casoli T, Di Stefano G, Balietti M, Solazzi M, Giorgetti B, Fattoretti P. Peripheral inflammatory biomarkers of Alzheimer’s disease: the role of platelets. Biogerontology. 2010 Oct;11(5):627–633.
   PubMed Web of Science ®Google Scholar
• Curti D, Malaspina A, Facchetti G, et al. (1996). Amyotrophic lateral sclerosis: oxidative energy metabolism and calcium homeostasis in peripheral blood lymphocytes. Neurology. 47, 1060–1064.
   PubMed Web of Science ®Google Scholar
• Domingues AF, Arduíno DM, Esteves AR, Swerdlow RH, Oliveira CR, Cardoso SM. Mitochondria and ubiquitin-proteasomal system interplay: relevance to Parkinson’s disease. Free Radic Biol Med. 2008 Sep 15;45(6):820–825.
   PubMed Web of Science ®Google Scholar
• Duhamel TA, Xu YJ, Arneja AS, Dhalla NS. Targeting platelets for prevention and treatment of cardiovascular disease. Expert Opin Ther Targets. 2007; 11: 1523–1533.
   PubMed Web of Science ®Google Scholar
• Elshamaa MF, Elghoroury EA, Helmy A. Intradialytic and postdialytic platelet activation, increased platelet phosphatidylserine exposure and ultrastructural changes in platelets in children with chronic uremia. Blood Coagul Fibrinolysis. 2009 Jun; 20(4):230–239.
   PubMed Web of Science ®Google Scholar
• Esteves AR, Domingues AF, Ferreira IL, et al. Mitochondrial function in Parkinson’s disease cybrids containing an nt2 neuron-like nuclear background. Mitochondrion. 2008 Jun;8(3):219–228.
   PubMed Web of Science ®Google Scholar
• Factor SA, Ortof E, Dentinger MP, Mankes R, Barron KD. Platelet morphology in Parkinson’s disease: an electron microscopic study. J Neurol Sci. 1994 Mar;122(1):84–89.
   PubMed Web of Science ®Google Scholar
• Fatah K, Hamsten A, Blombäck B, Blombäck M. Fibrin gel network characteristics and coronary heart disease: relations to plasma fibrinogen concentration, acute phase protein,serum lipoproteins and coronary atherosclerosis. Thromb Haemost. 1992; 68: 130–135.
   PubMed Web of Science ®Google Scholar
• Fristsma GA. Evaluation of hemostasis. In: Rodak BF, (editor): Hematology: clinical principles and applications, 2nd edition. Philadelphia, PA: W.B. Saunders Co; 2002.
   Google Scholar
• Fritsma GA. Evaluation of hemostasis. In: Rodak BF. Hematology Clinical Principles and Applications, 2nd ed. Philadelphia: WB Saunders; 2002.
   Google Scholar
• Hajimohammadreza I, Brammer MJ, Eagger S, Burns A, Levy R. Platelet and erythrocyte membrane changes in Alzheimer’s disease. Biochim Biophys Acta. 1990 Jun 27;1025(2):208–214.
   PubMedGoogle Scholar
• Hilgard P. The role of blood platelets in experimental metastases. Br J Cancer. 1973; 28: 429–435.
   PubMed Web of Science ®Google Scholar
• Hoogland G, Bos IW, Kupper F, van Willigen G, Spierenburg HA, van Nieuwenhuizen O, de Graan PN. Thrombin-stimulated glutamate uptake in human platelets is predominantly mediated by the glial glutamate transporter EAAT2. Neurochem Int. 2005 Dec;47(7):499–506.
   PubMed Web of Science ®Google Scholar
• Kiktenko AI, Zlobina GP, Brusov OS, Zakharova MN. Structure of peripheral blood platelets surface in patients with amyotrophic lateral sclerosis and multiple sclerosis. Zh Nevrol Psikhiatr Im S S Korsakova. 2005; 105(3):40–42.
   PubMedGoogle Scholar
• Kiktenko AI, Zlobina GP, Brusov OS, Zakharova MN. Structure of peripheral blood platelets surface in patients with amyotrophic lateral sclerosis and multiple sclerosis. Zh Nevrol Psikhiatr Im S S Korsakova. 2005;105(3):40–42.
   PubMedGoogle Scholar
• Kile BT. The role of the intrinsic apoptotic pathway in platelet life and death. J Thromb Haemost. 2009 Jul; 7 (Suppl 1):214–217.
   PubMedGoogle Scholar
• Kong J, Xu Z. Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1. J Neurosci. 1998; 18: 3241–3250.
   PubMed Web of Science ®Google Scholar
• Leytin V, Allen DJ, Mutlu A, Mykhaylov S, Lyubimov E, Freedman J. Platelet activation and apoptosis are different phenomena: evidence from the sequential dynamics and the magnitude of responses during platelet storage. Br J Haematol. 2008:142(3): 494–497.
   PubMed Web of Science ®Google Scholar
• Leytin V, Allen DJ, Mutlu A, Gyulkhandanyan AV, Mykhaylov S, Freedman J. Mitochondrial control of platelet apoptosis: effect of cyclosporin A, an inhibitor of the mitochondrial permeability transition pore. Lab Invest. 2009;89(4): 374–384.
   PubMed Web of Science ®Google Scholar
• Lin KH, Chang HC, Lu WJ, et al. Comparison of the relative activities of inducing platelet apoptosis stimulated by various platelet-activating agents. Platelets. 2009 Dec; 20(8):575–581.
   PubMed Web of Science ®Google Scholar
• Mendoza-Sotelo J, Torner C, Alvarado-Vásquez N, et al. Ultrastructural changes and immunolocalization of P-selectin in platelets from patients with major depression. Psychiatry Res. 2010 Apr 30;176(2-3):179–182.
   PubMed Web of Science ®Google Scholar
• Menzies FM, Ince PG, Shaw PJ. Mitochondrial involvement in amyotrophic lateral sclerosis. Neurochem Int. 2002 May; 40(6):543–551.
   PubMed Web of Science ®Google Scholar
• Michell AW, Luheshi LM, Barker RA. Skin and platelet alpha-synuclein as peripheral biomarkers of Parkinson’s disease. Neurosci Lett. 2005 Jun 24;381(3):294–298.
   PubMed Web of Science ®Google Scholar
• Nakano Y, Hirayama K, Terao K. Hepatic ultrastructural changes and liver dysfunction in amyotrophic lateral sclerosis. 1987;Arch Neurol. 44(1): 103–106.
   PubMedGoogle Scholar
• Perrotta PL, Perrotta CL, Snyder EL. Apoptotic activity in stored human platelets. Transfusion. 2003 Apr; 43(4):526–535.
   PubMed Web of Science ®Google Scholar
• Pignatelli P, Pulcinelli FM, Lenti, L, Gazzaniga PP, Violi F. Hydrogen peroxide is involved in collagen-induced platelet activation. Blood. 1998;91(2):484–490.
   PubMed Web of Science ®Google Scholar
• Pretorius E, Oberholzer HM, Smit E, Steyn E, Briedenhann S, Franz CR. Ultrastructural changes in platelet aggregates of HIV patients: a scanning electron microscopic study. Ultrastruct Pathol. 2008; 32: 75–79.
   PubMed Web of Science ®Google Scholar
• Pretorius E, Oberholzer HM. Ultrastructural changes of platelets and fibrin networks in human asthma: a qualitative case study. Blood Coagul Fibrinolysis. 2009;20:146–149. Epub 2009 Dec 9.
   PubMed Web of Science ®Google Scholar
• Pretorius E. The role of platelet and fibrin ultrastructure in identifying disease patterns. Pathophysiol Haemost Thromb. 2008;36(5):251–8. DOI: 10.1159/000252821.
   PubMedGoogle Scholar
• Prodan CI, Ross ED, Vincent AS, Dale GL. Differences in coated-platelet production between frontotemporal dementia and Alzheimer disease. Alzheimer Dis Assoc Disord. 2009 Jul-Sep;23(3):234–237.
   PubMed Web of Science ®Google Scholar
• Rosado JA, Redondo PC, Salido GM, G’omez-Arteta E, Sage SO, Pariente JA. Hydrogen peroxide generation induces pp60src activation in human platelets: Evidence for the involvement of this pathway in store-mediated calcium entry. J Biol Chem. 2004;279(3):1665–1675.
   PubMed Web of Science ®Google Scholar
• Sala G, Brighina L, Saracchi E, et al. Vesicular monoamine transporter 2 mRNA levels are reduced in platelets from patients with Parkinson’s disease. J Neural Transm. 2010 Sep;117(9):1093–1098.
   PubMed Web of Science ®Google Scholar
• Seno T, Inoue N, Gao D, et al. Involvement of NADH/NADPH oxidase in human platelet ROS production. Thromb Res. 2001;103(5): 399–409.
   PubMed Web of Science ®Google Scholar
• Shrivastava M, Das TK, Behari M, Pati U, Vivekanandhan S. Ultrastructural variations in platelets and platelet mitochondria-A novel feature in Amyotrophic Lateral Sclerosis. Ultrastruct Pathol. 2011 Apr;35(2): 52–59.
   PubMed Web of Science ®Google Scholar
• Shrivastava M, Vivekanandhan S, Pati U, Behari M, Das TK. Mitochondrial perturbance and execution of apoptosis in platelet mitochondria of patients with amyotrophic lateral sclerosis. Int J Neurosci. 2010(b) Dec 8. DOI: 10.3109/00207454.2010.537416 [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Swerdlow RH, Parks JK, Cassarino DS, Trimmer PA, Miller SW, Maguire DJ, Sheehan JP, Maguire RS, Pattee G, Juel VC, Phillips LH, Tuttle JB, Bennett JP Jr, Davis RE, Parker WD Jr. Mitochondria in sporadic amyotrophic lateral sclerosis. Exp Neurol. 1998 Sep;153(1): 135–42.
   PubMed Web of Science ®Google Scholar
• Swerdlow RH. Mitochondria in Cybrids Containing mtDNA from persons with mitochondriopathies. J Neurosci Res. 2007; 85:3416–3428.
   PubMed Web of Science ®Google Scholar
• Vielhaber S, Kunz D, Winkler K, et al. Mitochondrial DNA abnormalities in skeletal muscle of patients with sporadic amyotrophic lateral sclerosis. Brain. 2000;123: 1339–1348.
   PubMed Web of Science ®Google Scholar
• Wiedemann FR, Winkler K, Kuznetsov AV, et al. Impairment of mitochondrial function in skeletal muscle of patients with amyotrophic lateral sclerosis. J Neurol Sci. 1998;156, 65–72.
   PubMed Web of Science ®Google Scholar
• Wong PC, Pardo CA, Borchelt DR, et al. An adverse property of a familiar ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron. 1995; 14: 1105–1116.
   PubMed Web of Science ®Google Scholar
• Xu J, Shi C, Li Q, Wu J, Forster EL, Yew DT. Mitochondrial dysfunction in platelets and hippocampi of senescence-accelerated mice. J Bioenergetics Biomembranes. 2007;39(2): 195–202.
   PubMed Web of Science ®Google Scholar